Total Payments
$8,900
2024 Payments
$659.94
Companies
42
Transactions
535
Medicare Patients
3,455
Medicare Billing
$357,387
Payment Breakdown by Category
Food & Beverage$8,476 (95.2%)
Education$324.58 (3.6%)
Other$100.00 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,476 | 528 | 95.2% |
| Education | $324.58 | 6 | 3.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,299 | 112 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,133 | 60 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,012 | 58 | $0 (2023) |
| United Therapeutics Corporation | $626.48 | 25 | $0 (2024) |
| Grifols USA, LLC | $513.85 | 29 | $0 (2024) |
| Merck Sharp & Dohme LLC | $434.79 | 28 | $0 (2024) |
| Gilead Sciences, Inc. | $383.83 | 30 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $288.51 | 15 | $0 (2024) |
| Insmed, Inc. | $264.52 | 15 | $0 (2023) |
| Baxter Healthcare | $258.08 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $659.94 | 32 | AstraZeneca Pharmaceuticals LP ($148.99) |
| 2023 | $924.33 | 45 | Baxter Healthcare ($152.90) |
| 2022 | $601.65 | 33 | Baxter Healthcare ($81.46) |
| 2021 | $912.82 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($147.10) |
| 2020 | $875.43 | 48 | GlaxoSmithKline, LLC. ($161.20) |
| 2019 | $1,567 | 101 | GlaxoSmithKline, LLC. ($242.89) |
| 2018 | $1,747 | 116 | GlaxoSmithKline, LLC. ($329.06) |
| 2017 | $1,613 | 110 | GlaxoSmithKline, LLC. ($339.88) |
All Payment Transactions
535 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.22 | General |
| 09/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Pulmonology | ||||||
| 08/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Respiratory | ||||||
| 08/15/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $9.79 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 08/14/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Inflammation | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.00 | General |
| 06/11/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $17.93 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 05/14/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/09/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 04/25/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: Allergy/Immunology | ||||||
| 04/22/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Pulmonology | ||||||
| 03/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Immunology | ||||||
| 03/12/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 03/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Respiratory | ||||||
| 03/07/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Airway Clearance Device | ||||||
| 02/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/13/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 01/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 877 | 1,115 | $225,626 | $90,422 |
| 2022 | 13 | 752 | 983 | $188,622 | $77,834 |
| 2021 | 13 | 834 | 1,099 | $202,575 | $82,332 |
| 2020 | 17 | 992 | 1,392 | $273,877 | $106,798 |
Total Patients
3,455
Total Services
4,589
Medicare Billing
$357,387
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 84 | 119 | $63,665 | $20,093 | 31.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 126 | 205 | $37,310 | $18,948 | 50.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 159 | 238 | $30,226 | $14,598 | 48.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 84 | 85 | $20,315 | $8,635 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 89 | $14,685 | $8,428 | 57.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 111 | $12,432 | $6,812 | 54.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $16,695 | $6,262 | 37.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 52 | 52 | $5,408 | $1,989 | 36.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 25 | 25 | $4,425 | $1,398 | 31.6% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 41 | 41 | $4,346 | $1,097 | 25.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 21 | 23 | $1,725 | $902.98 | 52.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 16 | 16 | $10,560 | $482.57 | 4.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 15 | 16 | $2,656 | $457.78 | 17.2% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 12 | 12 | $300.00 | $112.08 | 37.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 14 | 14 | $574.00 | $104.13 | 18.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 16 | 16 | $304.00 | $104.10 | 34.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 154 | 242 | $44,044 | $19,307 | 43.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 52 | 94 | $50,145 | $16,342 | 32.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 145 | 209 | $26,543 | $11,591 | 43.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 69 | 72 | $17,208 | $7,621 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 67 | $11,055 | $6,218 | 56.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 99 | $11,088 | $5,939 | 53.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $6,615 | $2,618 | 39.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 27 | 27 | $4,779 | $2,058 | 43.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $4,602 | $2,042 | 44.4% |
About Emile Klada
Emile Klada is a Critical Care Medicine healthcare provider based in Sylvania, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2011. The National Provider Identifier (NPI) number assigned to this provider is 1316243355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emile Klada has received a total of $8,900 in payments from pharmaceutical and medical device companies, with $659.94 received in 2024. These payments were reported across 535 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,476).
As a Medicare-enrolled provider, Klada has provided services to 3,455 Medicare beneficiaries, totaling 4,589 services with total Medicare billing of $357,387. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Sylvania, OH
- Active Since 02/09/2011
- Last Updated 01/17/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316243355
Products in Payments
- NUCALA (Biological) $460.26
- TRELEGY ELLIPTA (Drug) $444.32
- OFEV (Drug) $441.33
- SYMBICORT (Drug) $425.27
- Prolastin-C Liquid (Biological) $404.08
- STIOLTO RESPIMAT (Drug) $396.71
- DUPIXENT (Biological) $349.82
- ORENITRAM (Drug) $283.25
- ZERBAXA (Drug) $283.01
- Arikayce (Drug) $264.52
- FASENRA (Biological) $248.82
- ANORO (Drug) $232.35
- Hillrom - Life 2000 Ventilation System (Device) $205.59
- TYVASO (Drug) $201.61
- FASENRA (Drug) $193.34
- XARELTO (Drug) $162.16
- BREO (Drug) $144.28
- GLASSIA (Biological) $141.93
- SPIRIVA RESPIMAT (Drug) $137.68
- The Vest System Model 105 Home Care (Device) $135.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Sylvania
Naeem Lughmani, Md, MD
Critical Care Medicine — Payments: $15,049
Critical Care Medicine $15,049
Nichole Miller
Critical Care Medicine — Payments: $2,168
Critical Care Medicine $2,168
Cierra Sell, Cnp, CNP
Critical Care Medicine — Payments: $189.12
Critical Care Medicine $189.12
Katina Gray
Critical Care Medicine
Critical Care Medicine
Mr. John Arvanitis, Rn,Mba, RN,MBA
Critical Care Medicine
Critical Care Medicine